Diag Capital Management »

Teva Pharmaceutical Industries shares owned by Diag Capital Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Diag Capital Management from 13F filings

Historical chart of Diag Capital Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Diag Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Diag Capital Management

Quarter filed Position value Share count Share price at filing
2018-12-31 $2.2M 140k 15.42

More positions owned by Diag Capital Management

Baxter International (BAX)
Athenex
Zimmer Holdings (ZBH)
Abbvie (ABBV)
Incyte Corporation (INCY)
Quanterix Ord (QTRX)
Celgene Corporation
Amgen (AMGN)
Foamix Pharmaceuticals
Medtronic (MDT)
Quotient
Pacira Pharmaceuticals conv
Takeda Pharmaceutical (TAK)
Abbott Laboratories (ABT)
Zai Lab (ZLAB)

View all positions for Diag Capital Management

Top funds holding Teva Pharmaceutical Industries

Ion Asset Management
Phoenix Holdings
Migdal Insurance & Financial Holdings
Millennium Management
Citadel Advisors
AustralianSuper Pty
Sound Shore Management
Goldman Sachs Group
Abrams Capital Management
Soleus Capital Management
Alyeska Investment Group
Legal & General Group
Holocene Advisors
Arrowstreet Capital, Limited Partnership
Sphera Funds Management

View all funds holding Teva Pharmaceutical Industries